Dashboard
Manage Tickers

PEN Penumbra Inc

NYSE penumbrainc.com


$ 225.00 $ 0.00 (0 %)    

Tuesday, 04-Nov-2025 07:00:10 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 623.20 $ 0.00 (0 %)
DIA $ 469.94 $ 0.00 (0 %)
SPY $ 675.79 $ 0.00 (0 %)
TLT $ 89.89 $ 0.00 (0 %)
GLD $ 367.50 $ 0.00 (0 %)
$ 226.19
$ 224.84
$ 225.00 x 182
$ 228.00 x 52
-- - --
$ 221.26 - $ 310.00
494,458
na
8.82B
$ 0.89
$ 59.72
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 07-29-2025 06-30-2025 10-Q
2 04-23-2025 03-31-2025 10-Q
3 02-18-2025 12-31-2024 10-K
4 10-30-2024 09-30-2024 10-Q
5 07-30-2024 06-30-2024 10-Q
6 05-07-2024 03-31-2024 10-Q
7 02-22-2024 12-31-2023 10-K
8 11-02-2023 09-30-2023 10-Q
9 08-01-2023 06-30-2023 10-Q
10 05-02-2023 03-31-2023 10-Q
11 02-23-2023 12-31-2022 10-K
12 11-03-2022 09-30-2022 10-Q
13 08-05-2022 06-30-2022 10-Q
14 05-03-2022 03-31-2022 10-Q
15 02-22-2022 12-31-2021 10-K
16 11-03-2021 09-30-2021 10-Q
17 08-09-2021 06-30-2021 10-Q
18 05-04-2021 03-31-2021 10-Q
19 02-23-2021 12-31-2020 10-K
20 11-02-2020 09-30-2020 10-Q
21 08-03-2020 06-30-2020 10-Q
22 05-07-2020 03-31-2020 10-Q
23 02-26-2020 12-31-2019 10-K
24 11-07-2019 09-30-2019 10-Q
25 08-06-2019 06-30-2019 10-Q
26 05-07-2019 03-31-2019 10-Q
27 02-26-2019 12-31-2018 10-K
28 11-05-2018 09-30-2018 10-Q
29 08-07-2018 06-30-2018 10-Q
30 05-08-2018 03-31-2018 10-Q
31 02-27-2018 12-31-2017 10-K
32 11-07-2017 09-30-2017 10-Q
33 08-08-2017 06-30-2017 10-Q
34 05-09-2017 03-31-2017 10-Q
35 02-28-2017 12-31-2016 10-K
36 11-03-2016 09-30-2016 10-Q
37 08-09-2016 06-30-2016 10-Q
38 05-09-2016 03-31-2016 10-Q
39 03-08-2016 12-31-2015 10-K
40 11-12-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

penumbra-presents-storm-pe-results-at-viva-2025-trial-data-shows-cavt-plus-anticoagulation-improves-functional-outcomes-than-anticoagulation-alone-in-pe-patients
Penumbra Presents STORM-PE Results At VIVA...
11/03/2025 20:06:41

The STORM-PE RCT data presented at the VIVA 2025 Conference showed PE patients treated with CAVT in combination with anticoagul...

deep-dive-into-penumbra-stock-analyst-perspectives-13-ratings
Deep Dive Into Penumbra Stock: Analyst Per...
10/27/2025 11:45:30

needham-reiterates-buy-on-penumbra-maintains-326-price-target
Needham Reiterates Buy on Penumbra, Mainta...
10/27/2025 09:44:42

Needham analyst Mike Matson reiterates Penumbra (NYSE:PEN) with a Buy and maintains $326 price target.

btig-reiterates-buy-on-penumbra-maintains-320-price-target
BTIG Reiterates Buy on Penumbra, Maintains...
10/27/2025 09:34:39

BTIG analyst Ryan Zimmerman reiterates Penumbra (NYSE:PEN) with a Buy and maintains $320 price target.

heres-how-much-you-would-have-made-owning-penumbra-stock-in-the-last-10-years
Here's How Much You Would Have Made Owning...
10/24/2025 14:45:57

truist-securities-maintains-buy-on-penumbra-lowers-price-target-to-300
Truist Securities Maintains Buy on Penumbr...
10/15/2025 15:32:40

Truist Securities analyst Richard Newitter maintains Penumbra (NYSE:PEN) with a Buy and lowers the price target from $310 to...

this-penumbra-analyst-turns-bullish-here-are-top-4-upgrades-for-wednesday
This Penumbra Analyst Turns Bullish; Here ...
10/08/2025 13:34:53

needham-upgrades-penumbra-to-buy-announces-326-price-target
Needham Upgrades Penumbra to Buy, Announce...
10/08/2025 11:16:12

Needham analyst Mike Matson upgrades Penumbra (NYSE:PEN) from Hold to Buy and announces $326 price target.

9-analysts-assess-penumbra-what-you-need-to-know
9 Analysts Assess Penumbra: What You Need ...
10/07/2025 18:01:11

evercore-isi-group-maintains-outperform-on-penumbra-lowers-price-target-to-285
Evercore ISI Group Maintains Outperform on...
10/07/2025 17:50:03

Evercore ISI Group analyst Vijay Kumar maintains Penumbra (NYSE:PEN) with a Outperform and lowers the price target from $300...

a-look-into-penumbra-incs-price-over-earnings
A Look Into Penumbra Inc's Price Over Earn...
10/03/2025 20:00:50

100-invested-in-penumbra-10-years-ago-would-be-worth-this-much-today
$100 Invested In Penumbra 10 Years Ago Wou...
10/03/2025 20:00:40

peering-into-penumbra-incs-recent-short-interest
Peering Into Penumbra Inc's Recent Short I...
10/02/2025 15:00:55

heres-how-much-100-invested-in-penumbra-10-years-ago-would-be-worth-today
Here's How Much $100 Invested In Penumbra ...
09/23/2025 22:00:22

this-accenture-analyst-is-no-longer-bullish-here-are-top-5-downgrades-for-wednesday
This Accenture Analyst Is No Longer Bullis...
09/03/2025 17:38:07

this-unisys-analyst-begins-coverage-on-a-bullish-note-here-are-top-5-initiations-for-wednesday
This Unisys Analyst Begins Coverage On A B...
09/03/2025 12:40:11

deep-dive-into-penumbra-stock-analyst-perspectives-9-ratings
Deep Dive Into Penumbra Stock: Analyst Per...
09/02/2025 13:01:21

this-penumbra-analyst-begins-coverage-on-a-bullish-note-here-are-top-5-initiations-for-tuesday
This Penumbra Analyst Begins Coverage On A...
09/02/2025 11:49:48

evercore-isi-group-initiates-coverage-on-penumbra-with-outperform-rating-announces-price-target-of-300
Evercore ISI Group Initiates Coverage On P...
09/02/2025 11:44:45

Evercore ISI Group analyst Vijay Kumar initiates coverage on Penumbra (NYSE:PEN) with a Outperform rating and announces Pric...

penumbra-appoints-shruthi-narayan-as-president-effective-sept-1
Penumbra Appoints Shruthi Narayan As Presi...
08/27/2025 13:01:37

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION